Can a new Non-Opioid drug replace opioids for Post-Surgery pain?

NCT ID NCT07723352

First seen Jul 23, 2026 · Last updated Jul 24, 2026 · Updated 1 time

Summary

This trial tests whether suzetrigine (Journavx), a newly approved non-opioid pain medication, can effectively control pain after thumb basal joint replacement surgery. One hundred adults aged 40 to 80 will receive suzetrigine plus acetaminophen for five days after surgery, and their pain levels will be tracked. The goal is to see if this drug can provide relief without the need for opioid painkillers.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
a non-opioid pain medication called suzetrigine (Journavx), taken as a 100 mg loading dose then 50 mg every 12 hours for 5 days, plus acetaminophen
What this could lead to
If effective, suzetrigine could offer a way to manage post-surgical pain without relying on opioids, reducing the risk of addiction and side effects.
What could go wrong
This is a small, single-arm trial with no comparison group, so results may not prove suzetrigine is better than standard care. Pain relief varies widely, and some people may still need opioids.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for JOINT REPLACEMENT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

osteoarthritis, hand Pain, Postoperative

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Rothman Orthopaedic Institute

    Philadelphia, Pennsylvania, 19107, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.